-
Industry leader Ed Shifflett, PhD joins MOMENTUS as Chief Growth Officer & Managing Partner
Written by
MOMENTUS BioPharma Consulting Group announced today that Ed Shifflett, PhD has joined the company as Chief Growth Officer and Managing Partner. John “Zeke” Czekanski, CEO, shared “The growth and trajectory of the company support Ed joining us as Chief Growth Officer and a full partner. Clients have responded extremely well to our forward-thinking strategies driven by innovative and integrated solutions across the therapeutic lifecycle. Ed’s experience building and scaling successful, client-focused businesses positions us well…
-
The MOMENTUS Approach to Readiness: Navigating the New Era of BioPharma Transformation
Written by
Biopharma leaders regularly tell us that the pace and magnitude of transformation are raising the bar for every decision. Data, speed, and advanced analytics are redefining how therapies are developed, accessed, and delivered, placing greater emphasis on value and, ultimately, better patient outcomes. Forward-thinking, cost-effective, nimble strategies that accelerate the approval and adoption of life-changing therapies are essential for successful partnerships with today’s biopharma clients. The MOMENTUS Readiness Platform was designed to meet this demand.…
-
Industry Leaders Scott Roberts and John “Zeke” Czekanski Launch MOMENTUS Biopharma Consulting
Written by
LANTANA, Fla., Nov. 5, 2025 /PRNewswire/ — Industry leaders Scott Roberts and John “Zeke” Czekanski announced today they have partnered to form MOMENTUS Biopharma Consulting, LLC (“MOMENTUS” or “the Company”), a purpose-built strategic consulting group. Headquartered in Lantana, FL with an additional location in Boston, MA, MOMENTUS offers integrated strategic solutions across the therapeutic life cycle, sharpening the focus on value and driving better outcomes for patients. The MOMENTUS platform will strive to harness new technologies, leverage Artificial Intelligence (AI), while offering human-input…
